The content on this site is intended for healthcare professionals only
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media from day 4 and 5 of ASCO 2021.
Alerts cover trials such as the Outback, SWOG1216, KEYNOTE052, CANTATA, CLEAR, PEACE-1, and PEACE-3.
Dr Morgan also mentions a study regarding sexual harassment in medicine and why it is a rising concern. In the end, he thanks the ASCO team for another great ASCO this year.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Best practice in precision medicine for prostate cancer
Transforming cancer care in India: The Access Cancer Care Initiative
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC
Laser oncosurgery - A new perspective in treating cancer
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
Understanding the use of PARPi combinations to treat patients with mCRPC
Neo-adjuvant therapy for different cancers in the Philippines
